UTHR Feb 2025 470.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 2.2000 |
| Open | 2.0000 |
| Bid | 1.4500 |
| Ask | 4.7000 |
| Strike | 470.00 |
| Expiry date | 2025-02-21 |
| Day's range | 2.0000 - 2.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
FX EmpireBig Money Elevating United Therapeutics
The medical devices and novel treatments United Therapeutics Corporation (UTHR) develops to treat pulmonary arterial hypertension (PAH) and other ailments are attracting substantial Big Money investment.
ZacksAre You a Growth Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Business WireUnited Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., June 27, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced the addition of former Minnesota Commissioner of Health Jan Malcolm to its Board of Directors. Ms. Malcolm was elected by the company’s shareholders at its annual meeting held on June 26, 2024.
© 2024 Yahoo. All rights reserved.